FDA panel votes to remove serious warning from Chantix label
Stephen FellerWASHINGTON, Sept. 15 (UPI) -- An advisory panel at the FDA voted to recommend the removal of a black box warning for psychological side effects of the drug smoking cessation drug Chantix.
CONCLUSION: Essential and dystonic vocal tremors responded differently to treatment. Dystonic vocal tremors responded significantly to treatment with botulinum toxin but not oral propranolol. Essential vocal tremors did not respond significantly to either treatment, perhaps due to the small number of patients, which is a limitation of this research.
CONCLUSION: Patients arrived very sick and displayed poor survival after deceased donor transplantation.
CONCLUSION: Except for the STOP-BANG questionnaire, subjective evaluation of sleepiness, sleep quality, perception of onset, and total sleep time are not important parameters for the diagnosis of obstructive sleep apnea, which reinforces the need for an active search for better management of these patients.
Supercomputer-enabled advances in science and engineering
Presents the table of contents for this issue of the publication.
Presents a listing of the editorial board, board of governors, current staff, committee members, and/or society editors for this issue of the publication.